Acadia Pharmaceuticals buy BiotechBee
Start price
03.01.23
/
60%
€15.65
Target price
31.12.25
€22.00
Performance (%)
23.98%
End price
05.05.23
€19.40
Summary
This prediction ended on 05.05.23 with a price of €19.40. The prediction had a final performance of 23.98%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acadia Pharmaceuticals | 2.840% | 2.840% | 10.428% | -16.231% |
| iShares Core DAX® | 2,59 % | 2,47 % | 8,84 % | 55,55 % |
| iShares Nasdaq 100 | -0,91 % | -6,46 % | 24,93 % | 73,04 % |
| iShares Nikkei 225® | 0,15 % | -8,77 % | 47,39 % | 63,78 % |
| iShares S&P 500 | -0,37 % | -1,22 % | 21,67 % | 61,03 % |
According to BiotechBee what are the pros and cons of Acadia Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Acadia Pharmaceuticals diskutieren
Buy mit Kursziel 22,0
In the thread Trading Acadia Pharmaceuticals
Buy beendet

